Search

You searched for "EAU"

161 results found

New techniques in UTI diagnosis

12 September 2023 | | Functional Urology, Infection
Urinary tract infection (UTI) is a common reason for seeking medical care in both primary and secondary settings. Half of women will have at least one episode of cystitis in their lifetime, and a third of them will have experienced...

Shared decision-making – minimising the mismatch

3 May 2024 | | Andrology, Basic Science Research, Endourology and Stones, Functional Urology, Infection, Neurourology, Paediatric Urology, Reconstructive Urology, Technological Developments, Trauma and Emergency Urology, Urologic Oncology, Uroradiology
In Western countries, we are spoilt for choice in almost every aspect of our lives, but does that reflect also in healthcare? While we have taken some big strides towards shared decision-making with our patients, the age-old physician dominance remains...

Education

PREDICT Prostate – individualised, evidence-based estimates of survival and treatment benefit

5 November 2019 | | Technological Developments, Urologic Oncology
Earlier this year ‘PREDICT Prostate’ was launched online alongside a high-profile publication in PLOS Medicine. The prognostic model and decision-aid has been designed to inform treatment decision-making among men newly diagnosed with non-metastatic prostate cancer. David Thurtle and Vincent Gnanapragasam...

Demanding cases or nightmares in uro-oncology? Sep/Oct 2022

5 September 2022 | | Urologic Oncology
Treatment of prostate cancer in renal transplant recipients is challenging due to a lack of knowledge of the natural history of cancer in these patients, the anatomical position of the graft in the iliac fossa and its proximity to the...

Rotterdam Prostate Cancer Risk app

1 July 2014 | | Urologic Oncology, Technological Developments
The widespread use of prostate specific antigen (PSA) testing has led to diagnostic difficulties for patients and urologists. The sensitivity and specificity characteristics of PSA are far from optimal. To try and improve the predictive accuracy of PSA measurements, nomograms...

In conversation with Mr Duncan Summerton

1 November 2018
Urology News was delighted to recently have a chat with Duncan Summerton, Consultant Urological Surgeon in Leicester and new President of BAUS. Duncan with a native wild brown trout caught on a dry fly on the Derbyshire Wye. Can you...

Ambulatory local anaesthetic implantation of percutaneous sacral nerve stimulators

11 July 2023 | | Functional Urology
Background The current treatment paradigm for detrusor overactivity (DO) and dysfunctional voiding (DV) includes conservative measures, pharmacotherapy, intravesical onabotulinum toxin A (Botox®), sacral nerve modulation (SNM / SNS) and urinary diversion as a last resort [1]. Incidence of DO is...

All you need to know about percutaneous nephrolithotomy: supine versus prone and mini versus traditional

1 September 2014 | | Endourology and Stones
Introduction Since the first percutaneous nephrolithotomy (PCNL), the technique has undergone many innovations, including modifications in positioning, miniaturisation of instruments and combination with retrograde intra-renal surgery (see Table 1 for an outline of the history of the technique). Controversy has...

Francisco Díaz (1527-1590), forefather of urology

4 March 2024 | | Technological Developments
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). We often talk about urology being the oldest surgical specialty and discuss the...

Metabolic screening and stone-prevention in urolithiasis patients

1 July 2017 | | Endourology and Stones
The incidence and prevalence of kidney stones is increasing [1,2]. Significant recurrence rates are noted with 14% of patients experiencing a further episode at one year, 35% at five years, and 52% at 10 years [3]. Over 10% of stone...

Immunotherapy in renal cancer

1 May 2019 | | Basic Science Research, Urologic Oncology
Renal cell carcinoma (RCC) is the sixth most common solid organ cancer in the UK. In 2018, there were 403,262 people diagnosed worldwide with the disease (2.2% of all cancer cases), and it accounted for 175,098 deaths in total (1.8%...